We have detected that you are using Internet Explorer to visit this website. Internet Explorer is now being phased out by Microsoft. As a result, NHS Digital no longer supports any version of Internet Explorer for our web-based products, as it involves considerable extra effort and expense, which cannot be justified from public funds. Some features on this site will not work. You should use a modern browser such as Edge, Chrome, Firefox, or Safari. If you have difficulty installing or accessing a different browser, contact your IT support team.
The prescribing and medicines data is required by NHS Digital to support vital analysis, linkage and sharing of data including for:
- COVID-19 surveillance
- COVID-19 medicines research
- the monitoring of data prescribed for COVID-19 patients
- the monitoring of prescribing patterns before, during and after COVID-19.
Scope of the collection
This Notice is served on:
- the NHS hospitals in England using the Cerner or WellSky EPMA systems which have agreed to participate in the collection.
Legal basis for provision of data
NHS Digital has been directed by the Secretary of State under section 254 of the Act to establish and operate a system for the collection and analysis of the information specified for this service.
Phase 1 of the collection will commence from June 2020, with Phase 2 due to begin in October 2020. Dates will be agreed with each participating trust.
In Phase 1, the collection will take data from 1 January 2020, followed by daily submissions (commencing August 2020) for a period of approximately 2 weeks.
In Phase 2, a collection will be made to cover a longer retrospective period, from 1 January 2019, followed by daily submissions to be continued until further notice.
The period of this collection will not continue past 31 March 2022, which is when its current legal basis – the COVID-19 Public Health Directions 2020 - expires.